BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15122672)

  • 1. Quantitation of simulated short echo time 1H human brain spectra by LCModel and AMARES.
    Kanowski M; Kaufmann J; Braun J; Bernarding J; Tempelmann C
    Magn Reson Med; 2004 May; 51(5):904-12. PubMed ID: 15122672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which prior knowledge? Quantification of in vivo brain 13C MR spectra following 13C glucose infusion using AMARES.
    Lanz B; Duarte JM; Kunz N; Mlynárik V; Gruetter R; Cudalbu C
    Magn Reson Med; 2013 Jun; 69(6):1512-22. PubMed ID: 22886985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different quantification algorithms may lead to different results: a comparison using proton MRS lipid signals.
    Mosconi E; Sima DM; Osorio Garcia MI; Fontanella M; Fiorini S; Van Huffel S; Marzola P
    NMR Biomed; 2014 Apr; 27(4):431-43. PubMed ID: 24493129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of lipids in skeletal muscle by LCModel and AMARES.
    Weis J; Johansson L; Ortiz-Nieto F; Ahlström H
    J Magn Reson Imaging; 2009 Nov; 30(5):1124-9. PubMed ID: 19780186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo proton magnetic resonance spectroscopic signal processing for the absolute quantitation of brain metabolites.
    Mandal PK
    Eur J Radiol; 2012 Apr; 81(4):e653-64. PubMed ID: 21515011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of signal-to-noise ratio and spectral linewidth on metabolite quantification at 4 T.
    Bartha R
    NMR Biomed; 2007 Aug; 20(5):512-21. PubMed ID: 17205487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of metabolite quantitation reproducibility in serial 3D-(1)H-MR spectroscopic imaging of human brain using stereotactic repositioning.
    Langer DL; Rakaric P; Kirilova A; Jaffray DA; Damyanovich AZ
    Magn Reson Med; 2007 Oct; 58(4):666-73. PubMed ID: 17899591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of in vivo ³¹P NMR brain spectra using LCModel.
    Deelchand DK; Nguyen TM; Zhu XH; Mochel F; Henry PG
    NMR Biomed; 2015 Jun; 28(6):633-41. PubMed ID: 25871439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pitfalls and advantages of different strategies for the absolute quantification of N-acetyl aspartate, creatine and choline in white and grey matter by 1H-MRS.
    Malucelli E; Manners DN; Testa C; Tonon C; Lodi R; Barbiroli B; Iotti S
    NMR Biomed; 2009 Dec; 22(10):1003-13. PubMed ID: 19504521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid and macromolecules quantitation in differentiating glioblastoma from solitary metastasis: a short-echo time single-voxel magnetic resonance spectroscopy study at 3 T.
    Crisi G; Orsingher L; Filice S
    J Comput Assist Tomogr; 2013; 37(2):265-71. PubMed ID: 23493217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intact metabolite spectrum mining by deep learning in proton magnetic resonance spectroscopy of the brain.
    Lee HH; Kim H
    Magn Reson Med; 2019 Jul; 82(1):33-48. PubMed ID: 30860291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo macromolecule signals in rat brain
    Simicic D; Rackayova V; Xin L; Tkáč I; Borbath T; Starcuk Z; Starcukova J; Lanz B; Cudalbu C
    Magn Reson Med; 2021 Nov; 86(5):2384-2401. PubMed ID: 34268821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-TE localised 1H MRS of the human brain at 3 T: quantification of the metabolite signals using two approaches to account for macromolecular signal contributions.
    Gottschalk M; Lamalle L; Segebarth C
    NMR Biomed; 2008 Jun; 21(5):507-17. PubMed ID: 17955570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of the neurochemical profile using simulated macromolecule resonances at 3 T.
    Schaller B; Xin L; Cudalbu C; Gruetter R
    NMR Biomed; 2013 May; 26(5):593-9. PubMed ID: 23413241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the influence of macromolecules and spline baseline in the fitting model of human brain spectra at 9.4T.
    Giapitzakis IA; Borbath T; Murali-Manohar S; Avdievich N; Henning A
    Magn Reson Med; 2019 Feb; 81(2):746-758. PubMed ID: 30329186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved quantification of in vivo 1H NMR spectra by optimization of signal acquisition and processing and by incorporation of prior knowledge into the spectral fitting.
    de Graaf AA; Bovée WM
    Magn Reson Med; 1990 Aug; 15(2):305-19. PubMed ID: 1975420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward accurate quantification of metabolites, lipids, and macromolecules in HRMAS spectra of human brain tumor biopsies using LCModel.
    Opstad KS; Bell BA; Griffiths JR; Howe FA
    Magn Reson Med; 2008 Nov; 60(5):1237-42. PubMed ID: 18836999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quantitation of glutamate in the brain by using MR proton spectroscopy at 1.5 T and 3 T].
    Gussew A; Rzanny R; Scholle HC; Kaiser WA; Reichenbach JR
    Rofo; 2008 Aug; 180(8):722-32. PubMed ID: 18512190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative test-retest reliability of metabolite values assessed with magnetic resonance spectroscopy of the brain. The LCModel versus the manufacturer software.
    Fayed N; Modrego PJ; Medrano J
    Neurol Res; 2009 Jun; 31(5):472-7. PubMed ID: 19215666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parameterized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases.
    Seeger U; Klose U; Mader I; Grodd W; Nägele T
    Magn Reson Med; 2003 Jan; 49(1):19-28. PubMed ID: 12509816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.